AAN Annual Meeting Programs: P5 - Poster Session 5 | American Academy of Neurology®

P5 - Poster Session 5

Event Time:	Thursday May 9, 2019 11:30 am to 6:30 pm
Topic(s):	Practice, Policy, and Ethics, General Neurology, Aging, Dementia, Cognitive, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), Headache, Movement Disorders, MS and CNS Inflammatory Disease, Neuro Trauma, Critical Care, and Sports Neurology, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-rehabilitation
Director(s):
Description:
Completion Message:
CME Credits:	0
Core Competencies:

Program Speakers - Tentative
Start/End Time	Title	Faculty
Currently there are no events in the timeline.

Disclosures
Speaker	Disclosure

Abstract Presenters
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	001	Undertreatment of Patients with Cluster Headache	Disclosure: Dr. Mannava has nothing to disclose.
Behaviorial and Cognitive Neurology: Language, Memory, and Visuoperception II
Start Time	Pub.	Title	Presenter
11:30 AM	001	Effect of Leukoaraiosis on Decline in Naming in Primary Progressive Aphasia	Disclosure: Dr. Odolil has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	001	Longitudinal Measures of Radiographic Outcomes as Predictors of Clinical Disability in Multiple Sclerosis: A 12-Year Study	Disclosure: Dr. Feng has nothing to disclose.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	001	Out with the Old and In with the New - Understanding Barriers and Facilitators in Obtaining "New" Blood Pressure Goal for Patients with Ischemic Stroke	Disclosure: Dr. Sico has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	001	A novel TTN deletion causes Autosomal Dominant Limb-Girdle Muscular Dystrophy with Dilated Cardiomyopathy	Disclosure: Dr. Rich has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	001	Long-term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Lennox Gastaut Syndrome in an Open-label Extension Trial (GWPCARE5)	Disclosure: Dr. Patel has received research support from Greenwich Biosciences given to Nationwide Children's Hospital.
Neuro-rehabilitation: Stroke Recovery
Start Time	Pub.	Title	Presenter
11:30 AM	001	Swallowing outcomes and discharge destinations in acute-stroke tube-feeding-dependent dysphagia patients treated with neuromuscular-electrical-stimulation during inpatient rehabilitation	Disclosure: Dr. Kushner has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	001	Medial temporal lobe subfield volumes are spared in non-amnestic Alzheimer's disease	Disclosure: Dr. Phillips has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	001	Striatal Acetylcholine and Dopamine are Necessary for Motor Function in Parkinsonism	Disclosure: Dr. Bamford has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	001	Utility of whole body 18-FDG-PET in management of Tuberculous Meningitis: A preliminary study from a tertiary care institute of North India	Disclosure: Dr. Modi has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	002	Acute Headache Diagnosis in the Emergency Department: Accuracy and Safety of an Artificial Intelligence System	Disclosure: Dr. Acosta has nothing to disclose.
Behaviorial and Cognitive Neurology: Language, Memory, and Visuoperception II
Start Time	Pub.	Title	Presenter
11:30 AM	002	Anatomical Correlates of Verbal Fluency in Parkinson Disease	Disclosure: Dr. Rodriguez-Porcel has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	002	Dietary and Lifestyle Factors in Multiple Sclerosis Progression: Results from a 5-year Longitudinal MRI Study	Disclosure: Dr. Hagemeier has nothing to disclose.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	002	Blood Pressure at Hospital Arrival Does Not Reliably Distinguish Hypertensive Intracerebral Hemorrhage	Disclosure: Dr. Fakhri has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	002	Relationships between DMD mutations and neurodevelopment in dystrophinopathy	Disclosure: Dr. Thangarajh has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Avexis.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	002	Evaluation of Withdrawal Seizures During Conversion from Antiepileptic Drug Regimens Containing Carbamazepine to Eslicarbazepine Acetate Monotherapy	Disclosure: Dr. Ramsay has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with UCB, Sunovion Pharmaceuticals Inc., Eisai, and Allied Group of Companies. Dr. Ramsay has received research support from Marinus, Sage, Sunovion Pharmaceuticals Inc., Eisai, and Lundbeck.
Neuro-rehabilitation: Stroke Recovery
Start Time	Pub.	Title	Presenter
11:30 AM	002	Functional anomaly mapping using BOLD time-courses reveals local and distant dysfunction caused by stroke	Disclosure: Dr. DeMarco has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	002	Synergistic neuropathology resulting from co-expression of TDP-43 and tau protein in vivo	Disclosure: Dr. Moszczynski has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	002	L-Dopa-Induced Dyskinesias are Reduced by Propranolol in Parkinsonian Mice	Disclosure: Dr. Bamford has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	002	Prophylactic Palmitoylethanolamide Prolongs Survival and Decreases detrimental Inflammation in Aged Mice with Bacterial Meningitis	Disclosure: Dr. Heide has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	003	Use of Traditional Medicine for Primary Headache Disorders in Kuwait.	Disclosure: Dr. Alshawaf has nothing to disclose.
Behaviorial and Cognitive Neurology: Language, Memory, and Visuoperception II
Start Time	Pub.	Title	Presenter
11:30 AM	003	Network-Based Approach to the Role of the Inferior Frontal Gyrus in Word Retrieval and Selection	Disclosure: Dr. Mass has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	003	Vitamin D and Tobacco Use and Long-Term Clinical and MRI Outcomes among CIS patients: 11-year Follow-up of BENEFIT.	Disclosure: Dr. Martinez-Lapiscina has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with CIHR, Research Manitoba, Multiple Sclerosis Society of Canada, Multiple Sclerosis Scientific Foundation, Crohn’s and Colitis Canada, National Multiple Sclerosis Society, CMSC.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	003	Low and steady: Evidence for target blood pressure 24 hrs post-thrombectomy	Disclosure: Dr. Elangovan has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	003	NEO1 and NEO-EXT Studies: Long-Term Safety of Repeat Avalglucosidase Alfa Dosing for 4.5 Years in Patients With Late-Onset Pompe Disease	Disclosure: Dr. Dimachkie has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alnylam, Audentes, CSL-Behring, Sanofi Genzyme, Momenta, NuFactor, RMS Medical, Shire Takeda and Terumo. Dr. Dimachkie has received research support from Alexion, Alnylam Pharmaceuticals, Amicus, Biomarin, Bristol-Myers Squibb, Catalyst, CSL-Behring, FDA/OPD, GlaxoSmithKline, Genentech, Grifols, MDA, NIH, Novartis, Genzyme, Octapharma, Orphazyme, UCB Biopharma, Viromed and TMA.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	003	Adherence to AED treatment for patients with focal seizure receiving monotherapy with eslicarbazepine acetate or prior generation generics: Evidence from a large US commercial claims database	Disclosure: Dr. Mehta has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sunovion Pharmaceuticals Inc.
Neuro-rehabilitation: Stroke Recovery
Start Time	Pub.	Title	Presenter
11:30 AM	003	Causes of interruption of acute rehabilitation and readmission after stroke	Disclosure: Dr. Herrmann has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	003	Predicting Clinical Course in Persons with Mild Cognitive Impairment using structural MRI.	Disclosure: Dr. Ezzati has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	003	Glial alpha-synuclein induces a unique transcriptional program in vivo	Disclosure: Dr. Olsen has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	003	Nontraumatic Spontaneous Pneumocephalus in Clostridium Septicum Central Nervous System Infection – A Case Report	Disclosure: Dr. Karukote has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	004	Filling the Gap: CSF Fistula as a Presentation of Intracranial Hypertension	Disclosure: Dr. Szewka has nothing to disclose.
Behaviorial and Cognitive Neurology: Language, Memory, and Visuoperception II
Start Time	Pub.	Title	Presenter
11:30 AM	004	The Contribution of Residual Anatomical Brain Networks in Language Recovery in Post-Stroke Aphasia	Disclosure: Dr. Kelkar has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	004	Adjusting neurofilament light levels using an MRI-based estimate of total axonal bulk improves its prediction of MS progression	Disclosure: Dr. Phillips has nothing to disclose.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	004	Sympathetic Nervous System Dysfunction Correlates with Increased Blood Pressure Variability after Acute Stroke	Disclosure: Dr. De Havenon has received research support from AMAG Pharmaceuticals and Regeneron Pharmaceuticals.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	004	GNE Myopathy Biomarkers: Essential for Diagnosis and Response to Therapy	Disclosure: Dr. Malicdan has received royalty, license fees, or contractual rights payments from Leadiant Biosciences. Dr. Malicdan has received research support from Leadiant Biosciences.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	004	Adjunctive Perampanel in Pediatric Patients with Epilepsy: Population Pharmacokinetic (PK) and Exposure-Response Analyses	Disclosure: Dr. Majid has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eisai Ltd.
Neuro-rehabilitation: Stroke Recovery
Start Time	Pub.	Title	Presenter
11:30 AM	004	The Relationship of Neurologic Impairments to Post-Stroke Fatigue in an Urban, Minority Population	Disclosure: Dr. Yee has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	004	Preliminary neuropathological findings in porcine brains following hypobaric exposure	Disclosure: Dr. Cook has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	004	Over Expression of PERK Suppresses the Neurodegenerative Phenotypes in PINK1 Mutant Flies by Enhancing Mitochondrial Function	Disclosure: Dr. Cui has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	004	Acute Disseminated Streptococcus Anginosus Abscesses in a Young Immunocompetent Patient	Disclosure: Dr. Khalife has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	005	An Interdisciplinary Approach Between Neurology and Neurosurgery for the Treatment of Headaches in the Setting of Aqueductal Stenosis	Disclosure: Dr. Baker has nothing to disclose.
Behaviorial and Cognitive Neurology: Language, Memory, and Visuoperception II
Start Time	Pub.	Title	Presenter
11:30 AM	005	Impaired Global Network Topology in Residual Connectomes in Stroke-induced Aphasia	Disclosure: Dr. Medaglia has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	005	A History of Migraine Headache is Associated with Worse Disability and Walking Speed in a Cohort of Patients with MS	Disclosure: Dr. Damian has nothing to disclose.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	005	High In-Hospital Systolic Blood Pressure Variability and Poor Functional Outcomes in Primary Intracerebral Hemorrhage Patients	Disclosure: Dr. Alex has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	005	The IPANEMA Study: Top Line Results from an Investigator-Initiated Multi-site Late-onset Pompe Disease Prevalence Study	Disclosure: Dr. Wencel has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	005	Long-Term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Dravet Syndrome in an Open-Label Extension Trial	Disclosure: Dr. Halford has received personal compensation for consulting from GW Pharma and NCGS. Dr. Halford has received research support from Takeda, GW Pharma, SK Life Sciences, The Epilepsy Study Consortium, Brain Sentinel, and Philips.
Neuro-rehabilitation: Stroke Recovery
Start Time	Pub.	Title	Presenter
11:30 AM	005	Repetitive Transcranial Magnetic Stimulation in Improving Lower Extremity Function and Gait Among Stroke Patients: A Meta-analysis	Disclosure: Dr. Matic has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	005	Connectomics in Brain Aging and Dementia	Disclosure: Dr. Chang has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	005	A kinome-wide Drosophila RNAi screen identifies glial adenylate kinases as modifiers of neuronal alpha-synuclein toxicity	Disclosure: Dr. Olsen has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	005	Listeria meningoencephalitis in an immunocompetent child	Disclosure: Dr. Kaul has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	006	Severity of Post-traumatic Headache in relation to Severity of TBI, PTSD and severe depression in Veterans of recent wars	Disclosure: Dr. Couch has received personal compensation in an editorial capacity for Springer.
Frontotemporal Dementia II
Start Time	Pub.	Title	Presenter
11:30 AM	006	Greater Relative White Matter Burden is a Distinct Feature of Tauopathies in Frontotemporal Degeneration Spectrum	Disclosure: Dr. Giannini has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	006	Serum Neurofilament Light Chain and Glial Fibrillary Acid Protein in Patients With Multiple Sclerosis	Disclosure: Dr. Ayrignac has nothing to disclose.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	006	Blood Pressure Variability Post Mechanical Thrombectomy And Outcomes	Disclosure: Dr. Vu has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	006	A Novel Homozygous TNNT1 Missense Mutation in a French-Canadian Kindred Causing a Unique Clinical and Pathological Phenotype of Congenital Nemaline Myopathy with Rods, Cores and Lobulated Fibers	Disclosure: Dr. Pellerin has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	006	Efficacy and Tolerability of Adjunctive Brivaracetam in Adults With Focal Seizures by Antiepileptic Drug Treatment History: Post Hoc Analysis	Disclosure: Dr. Klein has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Yes. Abbott: consultant; Alliance: medical advisory board; Acquestive: ad board; Eisai: consultant speaker; Lundbeck: research support; Sunovion: speaker; UCB Pharma: consultant, speaker.. Dr. Klein has received research support from Yes. Lundbeck.
Neuro-rehabilitation: Stroke Recovery
Start Time	Pub.	Title	Presenter
11:30 AM	006	A Pilot Study of Right Cerebellar tDCS as a Therapeutic Adjuvant in Chronic Aphasia after Left-Hemisphere Stroke	Disclosure: Dr. Dvorak has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	006	A Care Pathway for Post-Stroke Spatial Neglect: Initial Analysis of a Practice-Based Rehabilitation Research Network	Disclosure: Dr. Barrett has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with emedicine/WebMD. Dr. Barrett has received research support from Dart Neuroscience and Brightcloud International funded research projects she led through the Kessler Foundation.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	006	PBT434 Prevents a-synuclein Aggregation, Neuron Loss, Motor Dysfunction and Reduces Glial Cell Inclusions in a Transgenic Mouse Model of Multiple System Atrophy	Disclosure: Dr. Finkelstein has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Prana Biotechnology. Dr. Finkelstein has received research support from Prana Biotechnology.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	006	Late-Onset Austrian Syndrome in a Patient with Bacterial Meningitis	Disclosure: Dr. Shapouran has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	007	One and Done: A Case Series of Large Volume Occipital Nerve Blocks for the Treatment of Occipital Neuralgia	Disclosure: Dr. Mathew has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Avanir, Teva, Biomobie staff, Amgen, Allergan, Promius, and Takeda.. Dr. Mathew has received personal compensation in an editorial capacity for Practical Neurology. Dr. Mathew has received research support from Biomobie.
Frontotemporal Dementia II
Start Time	Pub.	Title	Presenter
11:30 AM	007	Plasma neurofilament light chain predicts disease progression in asymptomatic genetic frontotemporal dementia	Disclosure: Dr. Rojas -Martinez has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	007	The association between serum neurofilament light chain, atrophied lesion volume and brain atrophy with disability progression in multiple sclerosis	Disclosure: Dr. Tavazzi has nothing to disclose.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	007	Patients with Parenchymal Hemorrhagic Transformation and Poor Functional Outcome Have Distinct Systolic Blood Pressure Trajectories 72 hours After Mechanical Thrombectomy	Disclosure: Dr. Kodali has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	007	GNE Myopathy in Turkey: Clinical Features and Novel Mutations	Disclosure: Dr. Durmus has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	007	The proposed multimodal mechanism of action of cannabidiol (CBD) in epilepsy: modulation of intracellular calcium and adenosine-mediated signaling	Disclosure: Dr. Nichol has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities as an employee of Greenwich Biosciences Inc..
Neuro-rehabilitation: Stroke Recovery
Start Time	Pub.	Title	Presenter
11:30 AM	007	Effect of Training Eye Hand Coordination Using Emerging Natural User Interface Technologies for Improving Hand Function in Stroke Survivors- A Randomized Controlled Study	Disclosure: Dr. Choudhary has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	007	Machine Learning of Quantified Volumetric MR Imaging for Diagnostic Delineation of Alzheimer’s Dementia and Mild Cognitive Impairment in the Alzheimer's Disease Neuroimaging Initiative	Disclosure: Dr. Raji has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Brain reader.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	007	Dopaminergic Grafts Prevent Risk Of Secondary Parkinsonism In Cocaine Self-administering Rats	Disclosure: Dr. Venkiteswaran has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	007	Read Between the Lyme's: Case Series of Bannwarth Syndrome	Disclosure: Dr. Vu has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	008	Syndrome of Transient Headache and Neurological Deficits with Cerebrospinal Fluid Lymphocytosis (HaNDL): A Case Report with Newly Described Electroencephalography (EEG) findings, Symptomatic Treatment Strategies, and Literature Review	Disclosure: Dr. Hooshmand has nothing to disclose.
Frontotemporal Dementia II
Start Time	Pub.	Title	Presenter
11:30 AM	008	Progress and Participant Characterization in the Advancing Research and Treatment in Frontotemporal Lobar Degeneration (ARTFL) Rare Disease Clinical Research Consortium	Disclosure: Dr. Boxer has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with AbbVie, Asceneuron, Cellgene, Ipierian, Ionis, Janssen, Merck, Novartis, Toyama and UCB. Dr. Boxer holds stock and/or stock options in Alector and Aeton Therapeutics. Dr. Boxer has received research support from NIH, the Tau Consortium, the University of California Cures Alzheimer’s Disease program, the Bluefield Project to Cure FTD, Corticobasal Degeneration Solutions, and the following companies: Avid, Biogen, Bristol Myers Squibb, C2N Diagnostics, Cortice Biosciences, Eli Lilly, Forum Pharmaceuticals, Genentech, Roche and TauRx.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	008	HLA genotype as a marker of Multiple Sclerosis prognosis: results from a multicentric extension study	Disclosure: Dr. Lysandropoulos has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Ipsen Pharma.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	008	Examining the Mortality Benefit of Various Post Ischemic Stroke/TIA Hypertension Goals – an VA-based Observational Study	Disclosure: Dr. Sico has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	008	Long-Term Efficacy of Dichlorphenamide for the Treatment of Primary Periodic Paralysis (PPP)	Disclosure: Dr. Johnson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acceleron, Strongbridge, Vertex, Fulcrum, and AveXis. Dr. Johnson has received personal compensation in an editorial capacity for Continuum. Dr. Johnson has received royalty, license fees, or contractual rights payments from University of Rochester. Dr. Johnson has received research support from Acceleron, CSL Behring, Fulcrum, Vertex, and AveXis.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	008	Perampanel in Real-World Clinical Care of Patients with Epilepsy: Retrospective Phase IV Study 506 – Second Interim Analysis	Disclosure: Dr. Wechsler has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with for Alexza, Eisai, GW Pharmaceuticals, Lundbeck, Sunovion, Cyberonics, UCB Pharma, UCB Pharma, and Upsher-Smith.Dr. Wechsler has received research support from Alexza, Eisai, GW Pharmaceuticals, Lundbeck, Marinus, Pfizer, SK Life Science, Sunovion, UCB Pharma, and Upsher-Smith.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	008	Action Observation Training Increases Dynamic Functional Connectivity in Patients with Multiple Sclerosis	Disclosure: Dr. Cordani has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	008	Creutzfeldt-Jakob Disease (CJD) Presenting as Epilepsia Partialis Continua: An Uncommon Presentation	Disclosure: Dr. Milani has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	008	Study of Yerba Mate (Ilex Paraguariensis) as a Neuroprotective Agent of Dopaminergic Neurons in an Animal Model of Parkinson's Disease	Disclosure: Dr. Tribbia has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	008	Microvessel Cerebral Vasculitis and Peripheral Neuropathy as Neurologic Manifestations in Rocky Mountain Spotted Fever	Disclosure: Dr. Danielson has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	009	Quality of life in patients with cluster headache during the active periods	Disclosure: Dr. Kim has nothing to disclose.
Frontotemporal Dementia II
Start Time	Pub.	Title	Presenter
11:30 AM	009	Characteristics and Progress on 369 Subjects in the Longitudinal Evaluation Familial Frontotemporal Dementia Subjects (LEFFTDS) Protocol	Disclosure: Dr. Forsberg has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	009	No Association Between Lymphocyte Pharmacodynamics and Disability Following Alemtuzumab Treatment in Patients With Relapsing-Remitting Multiple Sclerosis	Disclosure: Dr. Meuth has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Almirall, Amicus Therapeutics Germany, Bayer, Biogen, Celgene, Chugai Pharma, Diamed, Genzyme, MedDay Pharmaceuticals, Merck Serono, Novartis, Novo Nordisk, ONO Pharma, QuintilesIMS, Roche, Sanofi-Aventis, and Teva. Dr. Meuth has received research support from Almirall, Amicus Therapeutics Germany, Bayer, Biogen, Celgene, Chugai Pharma, Diamed, Genzyme, MedDay Pharmaceuticals, Merck Serono, Novartis, Novo Nordisk, ONO Pharma, QuintilesIMS, Roche, Sanofi-Aventis, and Teva.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	009	Admission Blood Pressure and Outcome after Successful Recanalization: a collaborative pooled analysis	Disclosure: Dr. Anadani has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	009	A Survey of Patient-Identified Symptom Themes and Attitudes Toward Clinical Trials in Facioscapulohumeral Muscular Dystrophy (FSHD)	Disclosure: Dr. Shirilla has received research support from Acceleron Pharma.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	009	Study 506 – Second Interim Analysis of a Retrospective, Phase IV Study of Perampanel in Real-World Clinical Care of Patients with Epilepsy: Pediatric Subgroup (Aged <12 Years)	Disclosure: Dr. Moretz has nothing to disclose.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	009	Remotely Supervised Transcranial Direct Current Stimulation (RS-tDCS) Paired with a Hand Exercise Program to Improve Manual Dexterity in Progressive Multiple Sclerosis: A Randomized Sham Controlled Trial	Disclosure: Dr. Feinberg has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	009	Young-onset Creutzfeldt-Jakob disease with neuropsychiatric presentation and prolonged disease course	Disclosure: Dr. Dhanapalaratnam has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	009	Exploring the role of the basal ganglia in the control and learning of motor sequences in mice	Disclosure: Dr. Riccelli has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	009	Eisenmenger Syndrome presenting as Focal Seizures	Disclosure: Dr. English has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	010	A Tale of two headaches – Use of Dynamic CT Myelogram to Localize Cerebrospinal Fluid Leak	Disclosure: Dr. Schachter has nothing to disclose.
Cerebral Venous Sinus Thrombosis (CVST)
Start Time	Pub.	Title	Presenter
11:30 AM	010	Cerebral venous thrombosis from thrombocytosis in a patient with thalassemia and splenectomy	Disclosure: Dr. Osman has nothing to disclose.
Frontotemporal Dementia II
Start Time	Pub.	Title	Presenter
11:30 AM	010	The Multidomain Impairment Rating (MIR) Scale: Initial Reliability Data on a Multidimensional Scale for FTLD	Disclosure: Dr. Boeve has received research support from Biogen and Alector.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	010	Predicting EDSS in MS through Imaging Biomarkers Using Artificial Neural Networks	Disclosure: Dr. Chaar has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	010	A novel frameshift mutation in DNA2 causes early onset myopathy with velopharyngeal weakness and cardiac arrhythmias	Disclosure: Dr. Gonzalez Del Angel has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	010	Comparative Neuropsychological Effects of Carbamazepine and Eslicarbazepine Acetate	Disclosure: Dr. Meador has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Epilepsy Study Consortium for Eisai, GW Pharmaceuticals, NeuroPace, Novartis, Supernus, Upsher-Smith Laboratories, UCB Pharma and Vivus Pharmaceuticals. Dr. Meador has received research support from Sunovion.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	010	Clinical and fMRI Effects of Action Observation and Motor Imagery Training on Dual-Task Performances in Parkinson’s Disease Patients With Postural Instability and Gait Disorders	Disclosure: Dr. Sarasso has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	010	A case of Lymphomatosis Cerebri: a diagnostic challenge	Disclosure: Dr. Sheng has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	010	Progression of Parkinson’s Disease: A Longitudinal MRI Study of Functional Brain Connectome in a Large Cohort of Patients	Disclosure: Dr. Filippi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen Idec, Merk-Serono, Novartis, Teva Pharmaceutical Industries. Dr. Filippi has received personal compensation in an editorial capacity for Journal of Neurology. Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Teva Pharmaceutical Industries, Roche.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	010	A Rare Case of Mucormycosis Clivus Osteomyelitis Presenting With Stroke-Like Symptoms	Disclosure: Dr. Jacobson has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	011	Features of episodic cluster headache in the real world setting: clinical characteristics from a large, multi-national, cross-sectional survey	Disclosure: I am full-time employee and a stock shareholder of Eli Lilly and Company.
Cerebral Venous Sinus Thrombosis (CVST)
Start Time	Pub.	Title	Presenter
11:30 AM	011	Cerebral Venous Thrombosis In A Single Center Tertiary Hospital Of A South East Asian Country (CVSTS Study) – A Retrospective Study On The Clinical Profiles Of Patients with Cerebral Venous Thrombosis	Disclosure: Dr. Senga has nothing to disclose.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	011	Brain glucose metabolism in Lewy Body Dementia: implications for diagnostic criteria	Disclosure: Dr. CAMINITI has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	011	Loss of Brain Iron is Linked to Disability in Multiple Sclerosis - The Difference Between Concentration and Mass of Iron	Disclosure: Dr. Hagemeier has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	011	Carotid Artery Dissection in a Young Woman with Ullrich Congenital Muscular Dystrophy	Disclosure: Dr. Said-Said has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	011	Time Course of Efficacy and Tolerability Outcomes With Adjunctive Brivaracetam in Adults: A Post Hoc Analysis	Disclosure: Dr. Meador has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Epilepsy Study Consortium for Eisai, GW Pharmaceuticals, NeuroPace, Novartis, Supernus, Upsher-Smith Laboratories, UCB Pharma and Vivus Pharmaceuticals. Dr. Meador has received research support from Sunovion.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	011	Interventional First-Person Video Game Training Reduces Fall Risk in Parkinson’s Disease by Improving Gait, Contrast Sensitivity, Visual Acuity and Cognition	Disclosure: Dr. Koul has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	011	Different Patterns of Brain Activity During Lower Limb Movements in Parkinson’s Disease Patients With and Without Freezing of Gait	Disclosure: Dr. Piramide has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	011	Cryptococcus Strikes Again: Recurrent Cryptococcal Meningitis in an Immunocompetent Host	Disclosure: Dr. McDermott has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	012	Trend of Cluster Headache Hospitalizations and their Associated Outcomes, a National Four Year Retrospective Review.	Disclosure: Dr. Chung has nothing to disclose.
Cerebral Venous Sinus Thrombosis (CVST)
Start Time	Pub.	Title	Presenter
11:30 AM	012	Novel Oral Anticoagulants (NOACs) vs. Warfarin in the Treatment of Cerebral Venous Sinus Thrombosis (CVST): A retrospective study of functional and radiographic outcomes among patients enrolled in BEAST (Biorepository to Establish the Aetiology of Sinovenous Thrombosis) at UVA.	Disclosure: Dr. Wells has nothing to disclose.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	012	18F-AV-1451 Tau Tracer Uptake Correlates with Medial Temporal Lobe Subregional Atrophy in Amyloid Negative Individuals	Disclosure: Dr. Das has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Rancho Biosciences.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	012	Unilateral Motor Progression in Multiple Sclerosis: Association with a Single Critical Corticospinal Tract Lesion	Disclosure: Dr. Sechi has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	012	The Potential Role of Estrogen in Moderating Symptom Severity in Women with RYR1-Related Myopathy	Disclosure: Dr. Sharp has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	012	Long-term Retention on Adjunctive Brivaracetam in Adults With Focal Seizures Previously Exposed to Carbamazepine, Lamotrigine, Levetiracetam, or Topiramate: A Post Hoc Analysis	Disclosure: Dr. Chung has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Ucb, Sunovion, Lundbeck, Eisai. Dr. Chung has received research support from Ucb, SK Life Sciences.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	012	Motor Function of Individuals with HNRNPH2-related Disorders.	Disclosure: Dr. Salazar has received research support fromSMA Foundation, Biogen, Roche, AveXis, Mallinckrodt, Ultragenyx, PTC Therapeutics, Sarepta Therapeutics, and the Jain Foundation. .
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	012	Functional Network Connectivity Predicts Spreading of Cortical Atrophy in Parkinson’s Disease	Disclosure: Dr. Agosta has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	012	Comparison of Lumbar and Ventricular Cerebrospinal Fluid for Diagnosis and Monitoring of Meningitis	Disclosure: Dr. Kakadia has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	013	Intravenous Fosphenytoin as Rescue Treatment in Trigeminal Neuralgia Crisis	Disclosure: Dr. Schnell has nothing to disclose.
Cerebral Venous Sinus Thrombosis (CVST)
Start Time	Pub.	Title	Presenter
11:30 AM	013	Study of the factors predicting clinical outcome in patients with Cerebral Venous Sinus Thrombosis	Disclosure: Dr. Suhana has nothing to disclose.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	013	Abnormal neuropsychological memory testing and hippocampal volume in a clinical population.	Disclosure: Dr. Ruchinskas has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	013	The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis	Disclosure: Dr. Hemond has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	013	TTR Knockdown Therapy in Patients with hATTR Amyloidosis Who Have Disease Progression despite Liver Transplant	Disclosure: Dr. Moshe-Lilie has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	013	Experience with Eslicarbazepine Acetate Treatment at a Pediatric Epilepsy Center	Disclosure: Dr. Tanritanir has nothing to disclose.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	013	A Mixed-Methods Evaluation of Neurorehabilitation Resources for Pediatric Cerebral Malaria Survivors in Blantyre, Malawi	Disclosure: Dr. Boubour has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	013	Dual-Task in Parkinson’s Disease: A Gait Analysis and Functional MRI Study	Disclosure: Dr. Sarasso has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	013	Acute Chorea associated with Group C Streptococcus Pharyngitis	Disclosure: Dr. Zaribaf has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	014	Assessment and Management of Patients with Headache Referred to a General Neurology Consultation Service	Disclosure: Dr. Fearon has nothing to disclose.
Cerebral Venous Sinus Thrombosis (CVST)
Start Time	Pub.	Title	Presenter
11:30 AM	014	Cerebral Venous Thrombosis and Intracerebral Hemorrhage due to Pegaspargase Therapy for Acute Lymphoblastic Leukemia	Disclosure: Dr. Scarsella has nothing to disclose.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	014	Cholinergic-Related White Matter Lesion Load is Associated with Alzheimer’s Disease-Signature Cortical Thickness: The Northern Manhattan Study	Disclosure: Dr. Caunca has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	014	Oligoclonal band number as a predictor of multiple sclerosis disease course	Disclosure: Dr. Perrone has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	014	Lack of Genotype-Phenotype Correlation in Individuals with DMPK Expansions	Disclosure: Dr. Lindy has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with GeneDx.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	014	Inpatient Hospitalization Risk in Medicaid Patients with Epilepsy Before and After Perampanel Treatment	Disclosure: Dr. Chatterjee has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eisai inc..
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	014	Restoration of Barnes maze, Protein Kinase M? and MAP2 by Minocycline plus N-Acetylcysteine when first dosed 72 hours after experimental traumatic brain injury	Disclosure: Dr. Rahman has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	014	Microstructure alterations in the midbrain of Parkinson’s patients: a multishell diffusion MRI study	Disclosure: Dr. Chen has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	014	A Case of Neurobrucellosis in a non-endemic area	Disclosure: Dr. Bronstein has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	015	Acute and preventive treatment patterns in episodic cluster headache: findings from the United States, United Kingdom and Germany	Disclosure: Dr. Nichols has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eli Lilly and Company. Dr. Nichols holds stock and/or stock options in Eli Lilly and Company which sponsored research in which Dr. Nichols was involved as an investigator. Dr. Nichols holds stock and/or stock options in Eli Lilly and Company.
Cerebral Venous Sinus Thrombosis (CVST)
Start Time	Pub.	Title	Presenter
11:30 AM	015	Reactive thrombocytosis related cerebral venous thrombosis: A rare complication of untreated iron deficiency anemia	Disclosure: Dr. Vaddiparti has nothing to disclose.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	015	Periventricular Cerebral Blood Flow as a Biomarker for Cerebral Small Vessel Disease	Disclosure: Dr. Dolui has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	015	Cognition as a Disability Progression Marker: Two-Years Follow-Up of People with Multiple Sclerosis	Disclosure: Dr. Motyl has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Sanogi Genzyme, Novartis.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	015	mRna Expression Genes Associated To Myofibrillar Myopathies – Preliminary Study	Disclosure: Dr. Carvalho has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	015	Efficacy and Tolerability of Switching from Traditional Sodium Channel Blockers to Lacosamide in Epilepsy Patients	Disclosure: Dr. Kim has nothing to disclose.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	015	The cofilin/Limk1 pathway controls the rate of regenerating motor axons	Disclosure: Dr. Da Silva has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	015	Impaired midbrain networks connectivity underlies freezing of gait in Parkinson’s disease	Disclosure: Dr. Droby has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	015	Immunomodulating Biologics and sCJD	Disclosure: Dr. Lee has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	016	Idiopathic Orbital Inflammation Presenting as Hemicrania Continua	Disclosure: Dr. Duvall has nothing to disclose.
Cerebral Venous Sinus Thrombosis (CVST)
Start Time	Pub.	Title	Presenter
11:30 AM	016	Clinical course of seizures in patients with cerebral venous thrombosis	Disclosure: Dr. Uygun has nothing to disclose.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	016	Associations Between Amyloid Burden, White Matter Hyperintensities and Cognition in Cognitively Normal Older Adults	Disclosure: Dr. Chapin has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	016	Baló Concentric Sclerosis: Benign Evolution in a Tunisian Population	Disclosure: Dr. Landolsi has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	016	Transition to Adulthood in Duchenne/Becker Muscular Dystrophy	Disclosure: Dr. Donaldson has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	016	Analysis of Patient Characteristics and Outcomes by Prior AED use: Data from Pooled Observational Studies of Routine Perampanel use across Europe	Disclosure: Dr. Trinka has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with UCB, Eisai, Novartis, Gerrot-Lannach, BIAL, Takeda, Biogen, Newbridge, Sunovion. Dr. Trinka has received research support from Eisai Europe Ltd, GSK, Biogen-Idec, Novartis, Red Bull, Bayer, and UCB.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	016	Activity monitoring in neuromuscular disease: Successes, challenges, and a path forward	Disclosure: Dr. Lowes has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with AveXis, Inc., Bristol Meyers-Squibb, Pfizer, and Sarepta Therapeutics. Dr. Lowes has received research support from Novartis and Sarepta Therapeutics.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	016	Tracking Cortical Changes Throughout Cognitive Decline in Parkinson’s Disease: A Longitudinal MRI Study	Disclosure: Dr. Canu has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	016	Lyme Neuroborreliosis Initially Presenting as a Cavernous Sinus Syndrome: A Case Report	Disclosure: Dr. Rinehardt has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	017	Predictors of 30-Day Readmission Post Index Hospitalization for Cluster Headache: 5 Years National Estimate	Disclosure: Dr. Kim has nothing to disclose.
Cerebral Venous Sinus Thrombosis (CVST)
Start Time	Pub.	Title	Presenter
11:30 AM	017	Safety and Effectiveness of Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) in Patients with Concurrent Migraine Headaches and Focal Neurological Deficits.	Disclosure: Dr. Singh has nothing to disclose.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	017	Assessment of Deep Medullary Veins on 3T MRI in a Population-based Cohort	Disclosure: Dr. Ao has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	017	Serum GFAP Associates with Neurofilament Light and Disease Severity in Late Multiple Sclerosis	Disclosure: Dr. Airas has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Roche, Merck . Dr. Airas has received research support from Sanofi-Genzyme.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	017	A Novel Case of Overlapping of Myotonic Dystrophy Type 2 and Bethlem Congenital Muscular Dystrophy	Disclosure: Dr. Chalia has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	017	Study 506 – Second Interim Analysis of a Retrospective, Phase IV Study of Perampanel in Real-World Clinical Care of Patients with Epilepsy: Adolescent Subgroup (Aged 12 to <18 Years)	Disclosure: Dr. Segal has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eisai, Lundbeck, Nurticia, Novartis, Greenwich, Epitel, Encoded Therapeutics and Qbiomed.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	017	New treatments, now what: A pilot study investigating the use of in-home body-weight support harness systems to maximize the therapeutic benefit of novel treatments for spinal muscular atrophy.	Disclosure: Dr. Iammarino has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	017	Relationships Between Substantia Nigra Resting State Functional Connectivity and Uric Acid in REM Sleep Behavior Disorder and Parkinson’s Disease	Disclosure: Dr. Ellmore has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	017	Bartonella Papillitis Mimicking Anti-MOG Optic Neuritis	Disclosure: Dr. Sguigna has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	018	Accuracy of Pre-Headache Clinic SUNCT Diagnosis: A Cautionary Tale	Disclosure: Dr. Wax has nothing to disclose.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	018	Optical Properties and Oximetry Parameters of Cerebral Atrophic and Normal Regions in Healthy Volunteers	Disclosure: Dr. Roveri has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	018	Characterization of the Immunophenotype of Clinically Isolated Syndrome Patients Who Convert or Not To Multiple Sclerosis	Disclosure: Dr. Lee has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	018	Congestive Heart Failure is Strongly Associated with Hereditary Hemorrhagic Telangiectasia (HHT): Analysis of a Large National Database	Disclosure: Dr. Farooqui has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	018	X-Linked Myotubular Myopathy and Fragile X Syndrome in a Female Patient	Disclosure: Dr. Paul has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	018	Aura as a Predictor of Outcome after Epilepsy Surgery	Disclosure: Dr. Grossman has nothing to disclose.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	018	AbobotulinumtoxinA, onabotulinumtoxinA and incobotulinumtoxinA neurotoxin content and activity: Potential implications for duration of efficacy in patients	Disclosure: Dr. Field has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Ipsen.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	018	Longitudinal Evolution of White Matter Damage in Parkinson’s Disease	Disclosure: Dr. Scamarcia has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	018	Diagnostic Challenge: Sporadic Creutzfeldt-Jakob Disease (sCJD) Presenting with Isolated Visual Symptoms	Disclosure: Dr. Morawo has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	019	Healthcare resource use and humanistic burden associated with attack frequency in episodic cluster headache	Disclosure: Dr. Andrews has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eli Lilly and Company. Dr. Andrews holds stock and/or stock options in Eli Lilly and Company which sponsored research in which Dr. Andrews was involved as an investigator. Dr. Andrews holds stock and/or stock options in Eli Lilly and Company.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	019	Cognition predicted by brain biomarkers and demographic factors	Disclosure: Dr. Tsapanou has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	019	Late onset MS is associated with more severe longitudinal development of central brain atrophy compared to adult onset MS	Disclosure: Dr. Dujmic has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	019	Life Expectancy in Familial Cerebral Cavernous Malformation: An Analysis of Prospective Database	Disclosure: Dr. Arsalan has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	019	PYGM mRNA Expression In Patients With McArdle Disease: Demographic, Clinical, Genetic And Morphological Correlations.	Disclosure: Dr. Feder has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	019	Long-term Outcomes in Patients with Intractable Mesial Temporal Lobe Epilepsy who Undergo Laser Ablation.	Disclosure: Dr. Patel has nothing to disclose.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	019	Burden of Spasticity Among Patients and Caregivers: Results of a Multinational Survey	Disclosure: Dr. Patel has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merz and Allergan. Dr. Patel has received research support from Allergan, Merz, and Ipsen.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	019	Gray Matter Atrophy in Parkinson’s Disease and Freezing of Gait Assessed Using Surface-Based Algorithm	Disclosure: Dr. Kanovsky has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	019	Sarcoidosis to Nocardiosis: An odyssey of doubt and agony	Disclosure: Dr. Singh has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	020	Medical Cannabis Treatment in Patients with Trigeminal Neuralgia	Disclosure: Dr. Mechtler has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva, Promius, Allergan, Avanir, Amgen, Boston Biomedical, electroCore, Alder Biopharmaceuticals, Lilly. Dr. Mechtler has received research support from Dent Family Foundation.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	020	Increased Activity in Functional Brain Network among the Elderly with Youthful Memory in Superaging	Disclosure: Dr. Chun has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	020	Clinical Profile and functional outcomes of idiopathic inflammatory demyelinating disorders of CNS in adults.	Disclosure: Dr. Gorthi has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	020	Thyrotoxic Periodic Paralysis: An Unusual Presentation of Hyperthyroidism in a 20 year-old Male	Disclosure: Dr. Smith has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	020	Level Four Epilepsy Center Experience With Stereo-electroencephalography	Disclosure: Dr. Podkorytova has nothing to disclose.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	020	Economic evaluation of abobotulinumtoxinA vs onabotulinumtoxinA in real-life clinical management of post-stroke upper limb spasticity	Disclosure: Dr. Danchenko has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Ipsen Pharma.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	020	EEG-fNIRS Combined Neuroimaging Study on PD patients performing UPDRS Motor Tasks	Disclosure: Dr. Abtahi has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	020	Carbon Monoxide exposure, a red herring in a patient with rapidly progressive dementia, later diagnosed with Creutzfeldt-Jakob disease	Disclosure: Dr. Pang has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	021	Persistent Neurological Deficits in a Patient with Hemiplegic Migraine Revealing Diffuse Astrocytoma	Disclosure: Dr. Suneja has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	021	The Neural Substrate of Memory Impairment in the Oldest old with Dementia; The 90+ Study	Disclosure: Dr. Sajjadi has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	021	Real Life Evidence for CSF Neurofilaments Light Chain in Clinical Practice.	Disclosure: Dr. Carrillo-Loza has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	021	A Case of Dural A-V Fistula with Bilateral Thalamic Hyper-intensity	Disclosure: Dr. Komal Kumar has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	021	A NOVEL COMPOUND HETEROZYGOUS MUTATION IN TITIN LEADS TO CORE MYOPATHY WITH HEART DISEASE	Disclosure: Dr. Castoro has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	021	Altered resting-state network topology in drug-naïve idiopathic generalized epilepsy	Disclosure: Dr. Bin Kim has nothing to disclose.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	021	A study on Affordable Rehabilitation Care in Developing Countries with Use of Low Cost Technologies	Disclosure: Dr. Kokane has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	021	Initial Long-term Treatment with Rotigotine Maintains Striatal Dopamine Transporter Binding in De Novo Patients with Parkinson Disease	Disclosure: Dr. Ikeda has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	021	Aortic Fungus Ball – An Unusual Cause of Paraplegia	Disclosure: Dr. Natteru has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	022	Hypnic Headache: Characteristics and Treatment Modalities in An Academic Headache Center	Disclosure: Dr. Wax has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	022	Multimodal Magnetic Resonance Imaging versus 18F-FDG-PET to Identify Mild Cognitive Impairment	Disclosure: Dr. Dolui has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	022	Positive Predictive Value of Elevated Unique Cerebrospinal Fluid Oligoclonal Bands	Disclosure: Dr. Farin has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	022	Rapidly Progressive Cognitive Decline from a Dural AV Fistula	Disclosure: Dr. Berth has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	022	Diagnostic Challenges of Congenital Myopathies in the Adult Neuromuscular Clinic	Disclosure: Dr. Nicolau has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	022	Epilepsy MRI Interpretations Outside Of Comprehensive Epilepsy Centers Often Miss Epileptogenic Lesions	Disclosure: Dr. Ortiz-Guerrero has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	022	One Hundred Years of Innovation: Automatic Detection of Brain Ventricular Volume using Deep Learning in a Large-Scale Multi-Institutional Study	Disclosure: Dr. Han has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	022	Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping	Disclosure: Dr. Huang has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	022	Leprosy presenting as orofacial pain: case report.	Disclosure: Dr. Macedo has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	023	Sex-induced Headache Associated with Moyamoya Angiopathy: A Case Story and Literature Review	Disclosure: Dr. Chen has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	023	Clinical and Molecular PET Imaging Markers of Primary Progressive Aphasia due to Likely Alzheimer's Disease Pathology	Disclosure: Dr. Roll has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	023	Sex-specific Differences in Rim Appearance of Multiple Sclerosis Lesions on Quantitative Susceptibility Mapping	Disclosure: Dr. Tolaymat has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	023	Clinical and Radiographic Features of Multiple Intracranial Arteriovenous Malformations	Disclosure: Dr. Chiu has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	023	Incidence and Predictors of readmission in patients with Myasthenia Gravis: A National population-based cohort study (2010-14).	Disclosure: Dr. Singh has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	023	Epilepsy Surgery Outcomes in the setting of Encephalitis: A Case Series	Disclosure: Dr. Spurgeon has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	023	Abnormal DWI Signals of Spine in a Sporadic Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia caused by a novel c.1907T>A. Mutation in CSF1R	Disclosure: Dr. Li has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	023	Barriers and Characteristics of Caregiving Preparedness in Parkinson’s disease: a qualitative approach	Disclosure: Dr. Nwadiogbu has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	023	The Mysterious Mold: A Case of Coccidioides Meningitis	Disclosure: Dr. Slawski has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	024	Diagnostic Delay in Patients Prior to Being Seen in Headache Clinic	Disclosure: Dr. Puvvadi has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	024	The Relationship of Amyloid Beta in the Retina to that of the Brain is Burden-specific	Disclosure: Dr. Bissig has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	024	Demyelination, Inflammation and Axonal Loss Explain Different Patterns of Fractional Anisotropy Abnormalities in MS Cortical Normal Appearing Gray Matter and Lesions	Disclosure: Dr. Preziosa has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen Idec, Novartis and ExceMED.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	024	Is There Any Pivotal Association Between Smoking and Alpha-1 Antitrypsin Level and Function in Aneurysmal Subarachnoid Hemorrhage?	Disclosure: Dr. Ansari has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	024	LEMS with Anti-VGCC Antibodies and Dermatomyositis with Anti-TIF1-Gamma Antibodies: A Unique Case Study of Concomitant Autoimmune Neuromuscular Conditions without Malignancy	Disclosure: Dr. Isfort has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	024	Hospital Readmissions After an Epilepsy Related Surgical Intervention in the Nationwide Readmissions Database	Disclosure: Dr. Subramaniam has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	024	Clinical and Radiographic Characterization of Synthetic Cannabinoid-induced Toxic Leukoencephalopathy	Disclosure: Dr. Amar has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	024	What Bothers Parkinson Patients: Clinical Curation of their Verbatim Reports	Disclosure: Dr. Arbatti has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Grey Matter Technologies.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	024	Unilateral Periorbital and Facial Swelling with Multiple Unilateral Cranial Nerve Deficits in an Uncontrolled Diabetic	Disclosure: Dr. Dicken has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	025	One-Month Feasibility of Progressive Muscle Relaxation (PMR) via Smartphone Application for Post Traumatic Headache (PTH) Patients	Disclosure: Dr. Usmani has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	025	Diffusion Tensor Imaging in pre-dementia risk states: white matter atrophy findings in Mild Behavioral Impairment	Disclosure: Dr. Gill has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	025	3D MR image synthesis using unsupervised deep learning algorithm in MS patients	Disclosure: Dr. Jabarzedeh has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	025	Dynamic Cerebral Autoregulation and Personalized Blood Pressure Monitoring in Patients with Aneurysmal Subarachnoid Hemorrhage (aSAH)	Disclosure: Dr. Silverman has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	025	Response Rates in Placebo arm of MG Clinical Trials	Disclosure: Dr. Muppidi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alexion Pharmaceuticals.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	025	Epilepsy Surgery Trends In the United States, 2009–2014	Disclosure: Dr. Vellipuram has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	025	Cocaine Use Associated with Bilateral Globus Pallidus Changes; Similar to Carbon Monoxide intoxication.	Disclosure: Dr. Azeem has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	025	A Closer Look at the Unmet Needs, Research and Care Priorities for Women with Parkinson's	Disclosure: Dr. Feeney has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	025	Community-acquired Klebsiella pneumoniae meningitis. Questioning the demographic paradigm with new recommendations for diagnosis and effective treatment	Disclosure: Dr. Michaelson has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	026	Marijuana Use In Headache In a University–Based Headache Clinic	Disclosure: Dr. Schorn has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	026	Phenotypes and Biomarkers in Posterior Cortical Atrophy: Application of Consensus Clinical Diagnostic Criteria and the AT(N) Framework	Disclosure: Dr. McGinnis has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	026	A comparison of FLAIR and T1 maps from MP2RAGE at 7T for quantifying lesion volume and its correlation to disability in multiple sclerosis	Disclosure: Dr. Spini has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	026	Endovascular Therapy Versus Clipping For Aneurysmal Subarachnoid Hemorrhage, 2004-2014 Trends	Disclosure: Dr. Venkatraman has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	026	Congenital Myasthenic Syndrome with A Novel Agrin Gene Mutation	Disclosure: Dr. Giler has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	026	Contralateral hippocampal atrophy after temporal lobe surgery: volumetric analysis of preoperative and long-term postoperative MRI	Disclosure: Dr. Silva has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	026	Capecitabine Induced Leukoencephalopathy: Is there a correlation with liver metastases?	Disclosure: Dr. Ibrahim has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	026	SNCA G51D Missense Mutation Causing Juvenile Onset Parkinson’s Disease	Disclosure: Dr. Cooper has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	026	Pituitary Apoplexy Mimicking Meningoencephalitis: A Case Report and Literature Review	Disclosure: Dr. Chu has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	027	A Survey Comparing Neurology and Internal Medicine Residents’ Approaches to Headache Management	Disclosure: Dr. Cooper has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	027	Correlates between functional connectivity and amyloid deposition in healthy controls	Disclosure: Dr. Bruña has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Brainvestigations.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	027	New/Enlarging Lesion Count: Man versus Machine	Disclosure: Dr. Van Hecke has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with icometrix.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	027	Early Elevation of Plasma Lipocalin-2/NGAL is Associated with Poor Neurofunctional Outcome in Subarachnoid Hemorrhage Patients	Disclosure: Dr. Yu has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	027	The Diagnostic Yield of Repetitive Nerve Stimulation in Seropositive vs. Seronegative	Disclosure: Dr. Hua has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	027	The Pathogenesis and A Novel Surgical Approach to Treating Drug-Resistant Status Epilepticus Associated with Neurocysticercosis	Disclosure: Dr. Law has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	027	Tacrolimus Induced Osmotic Demyelination in Patient with Liver Transplantation	Disclosure: Dr. Pauta Martinez has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	027	Levodopa Responsiveness Subtypes of Freezing of Gait: Results Using a Levodopa Test	Disclosure: Dr. Factor has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Neurocrine, Lundbeck, Teva, Avanir, Sunovion, Adamas, Prexton, Biogen. Dr. Factor has received research support from Ipsen, Medtronics, Teva, US World Meds, Sunovion, Solstice, Vaccinex, Voyager, CHDI Foundation, Michael J. Fox Foundation, NIH.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	027	Suboxone abuse with shared needle as a cause of Botulism in an IV drug user	Disclosure: Dr. Roy has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	028	Undertreatment of Headache Associated with Sexual Activity	Disclosure: Dr. Cuneo has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	028	Association of Cortical and Subcortical Aß Deposition with Depressive and Anxiety Symptoms: A Population-based Cross-sectional Study	Disclosure: Dr. Krell-Roesch has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	028	Correlation Between Neurologic Challenge Task Performance and Lesion Localization of Sub-Threshold Lesions in Multiple Sclerosis Patients with EDSS Score of 0	Disclosure: Dr. Antoine has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	028	Novel explanation of angular remodeling in stent assisted coiling (SAC) of bifurcation aneurysms: Is it the stent or the coils?	Disclosure: Dr. Saied has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	028	Efficacy and limitations of cyclophosphamide in refractory myasthenia gravis	Disclosure: Dr. Garcia Trejo has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	028	VNS therapy vs. discontinuation of VNS therapy: Long-term seizure outcome	Disclosure: Dr. Gill has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	028	Is Acute Immunodeficiency Syndrome (AIDS) a risk factor for Central Pontine Myelinolysis (CPM).	Disclosure: Dr. Zeb has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	028	Altered Dopamine Transmission in Peripheral Mononuclear Cells in Parkinson's Disease	Disclosure: Dr. Saadatpour has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	028	Lyme disease presenting as multiple small cerebral infarcts of undetermined source.	Disclosure: Dr. Alcantara Lima has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	029	Functional brain connectome organization associated with atrophy and hypometabolism in posterior cortical atrophy	Disclosure: Dr. Migliaccio has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	029	Automatically segmented medulla oblongata volume as a surrogate for spinal cord atrophy in multiple sclerosis	Disclosure: Dr. Bergsland has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	029	Systematic Review of the Angiographic Evoluation of Neck Residual (Class II) Aneurysms	Disclosure: Dr. Maud has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	029	Assessment of disease severity in patients with Myasthenia Gravis – Clinical Phenotype and Immunological Correlation	Disclosure: Dr. Garuda has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title